Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ann V Schwartz

Showing results (1-10 of 169) with videos related to

Pageof 17
Sort By:
PPAR Research|September 17, 2008
TZDs and Bone: A Review of the Recent Clinical EvidenceAnn V Schwartz
PPAR Research|January 30, 2007
Diabetes, TZDs, and Bone: A Review of the Clinical EvidenceAnn V Schwartz
Diabetologia|April 29, 2017
Diabetes, bone and glucose-lowering agents: clinical outcomesAnn V Schwartz
Frontiers in Endocrinology|April 15, 2015
Marrow fat and bone: review of clinical findingsAnn V Schwartz
Bone|June 2, 2015
Epidemiology of fractures in type 2 diabetesAnn V Schwartz
Calcified Tissue International|July 28, 2016
Efficacy of Osteoporosis Therapies in Diabetic PatientsAnn V Schwartz
Current Osteoporosis Reports|January 20, 2020
MRI Assessment of Bone Marrow Composition in OsteoporosisXiaojuan Li, Ann V Schwartz
Expert Opinion on Drug Safety|January 4, 2008
Effect of thiazolidinediones on skeletal health in women with Type 2 diabetesAnn V Schwartz, Deborah E Sellmeyer
The Journal of Clinical Endocrinology and Metabolism|April 6, 2007
Thiazolidinediones: new evidence of bone lossAnn V Schwartz, Deborah E Sellmeyer
Nature Clinical Practice. Endocrinology & Metabolism|June 28, 2007
Does rosiglitazone adversely affect bone formation and bone mineral density in postmenopausal women?Ann V Schwartz, Steven R Cummings
Pageof 17

Showing results (1-10 of 169) with videos related to

Sort By:
Pageof 17
PPAR Research|September 17, 2008
TZDs and Bone: A Review of the Recent Clinical EvidenceAnn V Schwartz
PPAR Research|January 30, 2007
Diabetes, TZDs, and Bone: A Review of the Clinical EvidenceAnn V Schwartz
Diabetologia|April 29, 2017
Diabetes, bone and glucose-lowering agents: clinical outcomesAnn V Schwartz
Frontiers in Endocrinology|April 15, 2015
Marrow fat and bone: review of clinical findingsAnn V Schwartz
Bone|June 2, 2015
Epidemiology of fractures in type 2 diabetesAnn V Schwartz
Calcified Tissue International|July 28, 2016
Efficacy of Osteoporosis Therapies in Diabetic PatientsAnn V Schwartz
Current Osteoporosis Reports|January 20, 2020
MRI Assessment of Bone Marrow Composition in OsteoporosisXiaojuan Li, Ann V Schwartz
Expert Opinion on Drug Safety|January 4, 2008
Effect of thiazolidinediones on skeletal health in women with Type 2 diabetesAnn V Schwartz, Deborah E Sellmeyer
The Journal of Clinical Endocrinology and Metabolism|April 6, 2007
Thiazolidinediones: new evidence of bone lossAnn V Schwartz, Deborah E Sellmeyer
Nature Clinical Practice. Endocrinology & Metabolism|June 28, 2007
Does rosiglitazone adversely affect bone formation and bone mineral density in postmenopausal women?Ann V Schwartz, Steven R Cummings
Pageof 17